Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang
These investigations provide insight into how peptides can influence complex vascular and regenerative systems at a molecular level
Beyotime) were used for detection, followed by hematoxylin counterstaining
If you've been stable on semaglutide for 3+ months without further weight loss, have reached your target weight, or experience intolerable nausea and constipation, switching to a dual-mechanism compound like tirzepatide may offer better results